Are intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant?

dc.authorid0000-0002-8084-7855
dc.authorid0000-0003-2003-6337
dc.contributor.authorKaplan, Necati
dc.contributor.authorKaraaslan, Numan
dc.contributor.authorYılmaz, İbrahim
dc.contributor.authorYaşar Şirin, Duygu
dc.contributor.authorAkgün, Feride Sinem
dc.contributor.authorÇalışkan, Tezcan
dc.contributor.authorŞimşek, Abdullah Talha
dc.contributor.authorÖzbek, Hanefi
dc.date.accessioned2019-12-18T13:54:49Z
dc.date.available2019-12-18T13:54:49Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı
dc.description.abstractAIM: To investigate the effect of dabigatran, a new oral anticoagulant, on human primary cell cultures isolated from intact intervertebral disc tissue. MATERIAL and METHODS: Cell cultures were prepared from tissues obtained from six cases who had undergone surgery due to spinal trauma. Dabigatran, an active pharmacological agent, was applied to intact annulus fibrosus (AF)/nucleus pulposus (NP) primary cell cultures from the study group. After performing cell viability, toxicity, and proliferation tests on all cultures in the control and study groups, the surface morphologies of the samples were evaluated. Subsequently, chondroadherin (CHAD), cartilage oligomeric matrix protein (COMP), and matrix metalloproteinase (MMP)-13 and -19 expressions were measured via a real-time polymerase chain reaction (RT-PCR). Data were analyzed statistically. RESULTS: In the proliferation assays performed on the 20th day of the study, cells in the dabigatran-supplemented group were reported to have lost 46.37% more viability than those in the control group. Expressions of all genes examined except MMP-13 were evaluated in the control group by time, but in contrast to the control group results, COMP and MMP-19 gene expressions decreased in the dabigatran-treated group. No CHAD or MMP-13 expression was noted in these cultures. CONCLUSION: The potential for a systemically applied drug to accumulate in tissue and negatively affect surrounding tissues and microstructures must be emphasized.
dc.identifier.citationKaplan, N., Karaaslan, N., Yılmaz, İ., Yaşar Şirin, D., Akgün, F. S., Çalışkan, T. ... Özbek, H. (2019). Are intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant? Turkish Neurosurgical, 29(4), 470-477. https://doi.org/10.5137/1019-5149.JTN.24336-18.0
dc.identifier.doi10.5137/1019-5149.JTN.24336-18.0
dc.identifier.endpage477
dc.identifier.issn1019-5149
dc.identifier.issue4
dc.identifier.scopusqualityQ3
dc.identifier.startpage470
dc.identifier.urihttps://doi.org/10.5137/1019-5149.JTN.24336-18.0
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4527
dc.identifier.volume29
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Neurosurgical Society
dc.relation.ispartofTurkish Neurosurgicalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCytotoxicity
dc.subjectDabigatran
dc.subjectDeep Vein Thrombosis
dc.subjectIntervertebral Disc Cells
dc.subjectPrimary Cell Cultures
dc.titleAre intervertebral disc tissue cells damaged when attempting to prevent thrombus formation using dabigatran, a new oral anticoagulant?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Ozbek, Hanefi-2019.pdf
Boyut:
1.01 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: